Skip to content
Lower risk Drug recall · FDA · Published April 25, 2019

Dermoplast Spray Recall: Incorrect Net Weight Labeling

Advantice Health recalls Dermoplast Anesthetic Pain & Itch spray canisters due to incorrect net weight labeling. Check your lot number and expiration date.

🇺🇸 FDA recall #D-1279-2019DrugDermoplast ›
Take action

Contact the company

Recalling firmAdvantice Health7 E Frederick Pl Ste 100 · Cedar Knolls, NJ 07927-1815
✎ GovInfoNow plain-language explainer

Advantice Health is recalling Dermoplast Anesthetic Pain & Itch spray canisters because the label incorrectly states the net weight is 2.75 oz instead of the correct 2.0 oz. This affects approximately 111,492 canisters distributed nationwide in the USA. The product contains benzocaine and menthol. Read more at govinfonow.com/recall/38874-dermoplast-spray-recall-incorrect-net-weight-labeling.

Source Summary by GovInfoNow · govinfonow.com/recall/38874-dermoplast-spray-recall-incorrect-net-weight-labeling · Updated October 11, 2026 · FDA enforcement record: FDA #D-1279-2019

Cite this page

“Dermoplast Spray Recall: Incorrect Net Weight Labeling.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/38874-dermoplast-spray-recall-incorrect-net-weight-labeling. Based on FDA recall #D-1279-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1279-2019%22&limit=1).

Advantice Health recalled Dermoplast Anesthetic Pain & Itch Spray canisters due to labeling errors stating an incorrect net weight, the FDA said on April 25, 2019. The recall affects 111,492 units distributed nationwide.

How to tell if you have it

  • Brand: Dermoplast
  • Product: Anesthetic Pain & Itch Spray
  • UPC: 8 51409 00722 6
  • Lot #: 14049A, Exp 12/21
  • Quantity: 111,492 canisters

The hazard

The canisters incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz., according to the FDA.

Context

GovInfoNow's records show other recent recalls of similar products include ICU Medical Recalls Potassium Chloride Injection Due to Label Error (2025-10-29), Pro N: 5% Lidocaine Tattoo Numbing Spray Recall - Cgmp Deviations (2026-02-02), and Nivagen Zinc Oxide Ointment Recall: C G M P Deviations (2025-10-31).

How to tell if you have this one

Look for Dermoplast Anesthetic Pain & Itch spray canisters with a net weight labeled as 2.75 oz (78g). Check for UPC 8 51409 00722 6, Lot # 14049A, and an expiration date of 12/21.

  • Brand
    Dermoplast
  • Product
    Dermoplast Anesthetic PAIN & ITCH (benzocaine and menthol) SPRAY canisters, 20%, 0.5%, Net WT 2.75 oz (78g)
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide in the USA
Recall numberProduct, codes & lots
D-1279-2019Dermoplast Anesthetic PAIN & ITCH (benzocaine and menthol) SPRAY canisters, 20%, 0.5%, Net WT 2.75 oz (78g); Distributed by Moberg Pharma North America LLC, Cedar Knolls, NJ 07927; UPC 8 51409 00722 6; Lot #: 14049A, Exp 12/21
D-1280-2019Dermoplast Anesthetic PAIN & ITCH (benzocaine and menthol) SPRAY canisters, 20%, 0.5%; full case of 12-2 oz. cans only; Distributed by Moberg Pharma North America LLC, Cedar Knolls, NJ 07927; Product Code 80-6802; Case UPC 1 03 16864 68002 7.; Lot #: 14049A, Exp 12/21

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Apr 25, 201912. Published in FDA’s Enforcement Report: May 8, 201923. FDA classified it Class III: May 14, 201934. FDA terminated the recall: Feb 11, 2021420192021
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class III
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1279-2019 (April 25, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1279-2019 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA